CRHR1 and ovarian carcinoma: In the present study, we examined the distribution of CRH, CRHR1, CRHR2 and FasL peptides in ovarian carcinoma and we investigated the potential role of CRH and FasL in modulating the immune defenses of ovarian cancer cells.